AKT1 and esophageal squamous cell carcinoma: Importantly, the stimulatory effect of SOX9 on the proliferation of ESCC cells was drastically reduced upon treatment with an Akt inhibitor (Figure 6E), demonstrating that functional Akt activation is vital to the biological effects of SOX9 in ESCC cells.